Skip to main content
Franchise Global Health Inc. logo

Franchise Global Health Inc. — Investor Relations & Filings

Ticker · FGH ISIN · CA35180D1096 LEI · 894500SLRW2DE9DKLP68 TSXV Wholesale and retail trade
Open in API
Filings indexed 83 across all filing types
Latest filing 2022-12-29 Regulatory Filings
Country CA Canada
Listing TSXV FGH

About Franchise Global Health Inc.

https://franchiseglobalhealth.com/

Franchise Global Health Inc. is a multi-national operator specializing in the medical cannabis and pharmaceutical industries. The company functions as a fully integrated medical cannabis provider, leveraging expertise in genetics and cultivation. Its core focus is the European market, particularly Germany, where it distributes medical cannabis, cannabis products, pharmaceutical products, and medical devices.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed by Franchise Global Health Inc. It details a material corporate event: the acquisition of Franchise Global Health Inc. by Flora Growth Corp. via a statutory plan of arrangement, resulting in Franchise becoming a wholly-owned subsidiary of Flora. The document includes specifics about the transaction, share exchange ratio, stock option treatment, and the de-listing of Franchise shares from the TSX Venture Exchange. It also references the filing of the arrangement agreement and management information circular on SEDAR. This type of filing is a regulatory disclosure of a material corporate change, not a full annual or interim financial report, nor a proxy or voting result announcement. It is a formal regulatory filing reporting a significant corporate event, fitting the category of Regulatory Filings (RNS). The document length is about 4,821 characters, which is substantive and contains detailed information about the transaction, not just a brief announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2022-12-29 English
News release - English.pdf
Merger & Acquisition Classification · 95% confidence The document is a press release announcing the completion of a Plan of Arrangement (a type of acquisition) between Franchise Global Health Inc. and Flora Growth Corp. It details the transaction terms, shareholder approvals, share exchange ratios, and the expected delisting of Franchise Global Health from the TSX Venture Exchange. The document does not contain financial statements or detailed financial analysis but rather describes the completion of a merger/acquisition transaction and related corporate actions. This fits the definition of a Merger & Acquisition (MA) filing, which includes announcements and documents related to merger proposals or takeover bids. The document is not a full annual or interim report, nor is it a regulatory filing or announcement of a report publication. Therefore, the appropriate classification is MA with high confidence.
2022-12-24 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Condensed Consolidated Interim Financial Statements' for Franchise Global Health Inc. as of September 30, 2022 and 2021. It contains detailed financial statements including Statements of Financial Position, Comprehensive Loss, Changes in Equity, and Cash Flows, along with extensive notes. The presence of quarterly and nine-month financial data, unaudited status, and the term 'Interim' clearly indicate this is a financial report for a period shorter than a full fiscal year. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-11-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three and nine months ended September 30, 2022 and 2021. It discusses the company's financial condition, results of operations, business overview, strategy, and outlook. It references unaudited condensed consolidated interim financial statements and is prepared under Canadian securities regulations (NI 51-102). The document contains substantive financial and operational analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not a brief announcement or a certification letter, nor is it a full annual report or earnings release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2022
2022-11-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CEO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. It explicitly states it is a certification related to interim filings, not the filings themselves. The document is short (3036 characters) and primarily an officer certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the interim report itself (IR).
2022-11-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the Chief Financial Officer regarding the interim financial report and interim MD&A for the period ended September 30, 2022. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The content is primarily an officer certification attesting to the accuracy and fair presentation of the interim filings, without containing the actual financial data or analysis itself. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is 3029 characters, which is relatively short and consistent with a certification letter rather than a full interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-11-29 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.